Isotretinoin Ennogen Ip

Isotretinoin, the active ingredient in Isotretinoin Ennogen Ip, is a retinoid presented as an oral dosage form for oral use. It is indicated for severe nodular acne and acne vulgaris that have not responded to conventional therapies.

GNH USA supplies Isotretinoin Ennogen Ip as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows strict quality standards and regulatory requirements to ensure product integrity.

Isotretinoin is a retinoid that targets the pathophysiology of severe acne. - Severe nodular acne: reduces inflammatory lesions and prevents formation of new nodules. - Acne vulgaris refractory to other treatments: improves skin clearance when standard therapies fail. - Cystic acne: decreases cyst formation and promotes faster healing of existing lesions.

Isotretinoin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dry skin and mucous membranes: leading to itching and discomfort. - Cheilitis (cracked lips): frequent during therapy. - Elevated triglycerides: may require monitoring. - Photosensitivity: increased skin reaction to sunlight.

Serious or Rare Side Effects: - Severe depression or suicidal ideation: requires immediate medical attention. - Inflammatory bowel disease: rare but serious gastrointestinal inflammation. - Hepatotoxicity: elevated liver enzymes indicating liver injury. - Hypervitamin A syndrome: symptoms of toxicity due to excess retinoid activity.

When prescribing Isotretinoin, clinicians should observe several safety measures. - Pregnancy contraindication: drug is teratogenic, avoid use in women of childbearing potential. - Effective contraception: require two reliable methods during treatment and for one month after. - Liver function monitoring: assess hepatic enzymes before and during therapy. - Lipid profile monitoring: check triglycerides and cholesterol regularly. - Avoid vitamin A supplements: additional retinoids can increase toxicity risk. - Store below 25°C: keep in the original packaging, protect from moisture and light.

Isotretinoin interacts with several medicines; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - Tetracycline antibiotics: concurrent use can increase intracranial pressure risk. - Vitamin A derivatives (e.g., retinol, acitretin): additive teratogenic and toxicity potential.

Moderate Interactions (Monitor Closely): - Systemic corticosteroids: may reduce isotretinoin efficacy. - Anticoagulants (warfarin): isotretinoin may enhance anticoagulant effect. - Lithium: potential for increased neuropsychiatric side effects.